CardioArt Technologies is developing technology for the noninvasive measurement of various hemodynamic parameters. The technology enables both medical personnel and patients to obtain hemodynamic parameters noninvasively, yielding a substantial reduction in the risks involved with procedures such as right heart catheterization.
The company's first product line is focused on the treatment of patients with congestive heart failure.